Oscar Health, Inc. (NYSE:OSCR) Insider Sells $117,809.28 in Stock

Oscar Health, Inc. (NYSE:OSCR) insider Mario Schlosser sold 6,516 shares of the company’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $18.08, for a total transaction of $117,809.28. Following the completion of the transaction, the insider now owns 81,962 shares of the company’s stock, valued at approximately $1,481,872.96. This trade represents a 7.36 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Oscar Health Stock Down 2.4 %

NYSE OSCR traded down $0.44 during trading hours on Tuesday, reaching $17.99. 6,121,611 shares of the company’s stock were exchanged, compared to its average volume of 3,427,490. The company’s 50-day moving average is $17.33 and its two-hundred day moving average is $17.99. Oscar Health, Inc. has a one year low of $7.50 and a one year high of $23.79. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73. The company has a market capitalization of $4.45 billion, a price-to-earnings ratio of -307.12 and a beta of 1.64.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). The firm had revenue of $2.42 billion during the quarter, compared to analyst estimates of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business’s revenue was up 68.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.29) EPS. On average, analysts forecast that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.

Institutional Investors Weigh In On Oscar Health

A number of hedge funds and other institutional investors have recently bought and sold shares of OSCR. KBC Group NV boosted its stake in shares of Oscar Health by 41.2% in the 3rd quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after purchasing an additional 1,328 shares during the last quarter. Point72 Hong Kong Ltd bought a new stake in Oscar Health during the 2nd quarter worth approximately $78,000. Quest Partners LLC purchased a new stake in Oscar Health during the second quarter worth about $93,000. Optimum Investment Advisors bought a new position in shares of Oscar Health during the 3rd quarter valued at approximately $142,000. Finally, Amalgamated Bank increased its stake in shares of Oscar Health by 27.7% during the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after purchasing an additional 1,458 shares during the last quarter. Institutional investors own 75.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on OSCR. Piper Sandler reiterated an “overweight” rating and set a $28.00 price objective on shares of Oscar Health in a research report on Tuesday, September 10th. Bank of America cut shares of Oscar Health from a “neutral” rating to an “underperform” rating and lowered their price objective for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. Finally, UBS Group initiated coverage on Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective for the company. One analyst has rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $22.93.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.